Drug recall · July 27, 2022
Aripiprazole Tablets recall
Why: Failed dissolution specifications: OOS for dissolution at the 12-month stability time point.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Aripiprazole Tablets, USP 20 mg, packaged in a) 1,000-count bottle (NDC 60505-2676-8, UPC 3 60505 26768 2), b) 30-count bottle (NDC 60505-2676-3, UPC 3 60505 26763 7), Rx only, Manufactured by: Apotex, Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326
- Lots / codes
Lots: a) TD9591 Exp. 04/2023; b) TD9592 Exp. 04/2023
- Quantity
- 2010 bottles
- Company
- Apotex Corp., Weston, FL
- Distribution
- USA Nationwide
- Initiated
- July 7, 2022 · Voluntary: Firm initiated
- Classified
- July 21, 2022
- Reported
- July 27, 2022
- Ended
- September 22, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Aripiprazole
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.